Grant Street Asset Management, Inc. Amgen Inc Transaction History

Grant Street Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $43,913 - $48,718	-188 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $18,196 - $21,205	82 Added 77.36%	188 $47,000
Q4 2020 Mar 02, 2021	BUY	$216.38 - $257.67 $22,936 - $27,313	106 New	106 $24,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Grant Street Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Grant Street Asset Management, Inc. with notifications on news.